COVID-19 causes 'hyperactivity' in blood-clotting cells – @theU

Researchers found that inflammatory proteins produced by the virus significantly alter the function of platelets.

COVID-19 Causes 'Hyperactivity' in Blood-Clotting Cells

Mechanisms of endothelial activation, hypercoagulation and

Frontiers Long COVID: The Nature of Thrombotic Sequelae

Coronavirus blood-clot mystery intensifies

Ivermectin for COVID-19 Treatment: Clinical Response at Quasi

Life, Free Full-Text

Vaccines and blood clots? COVID blood clots are a greater concern

COVID-19 causes 'hyperactivity' in blood-clotting cells

Frontiers Hematological alterations associated with long COVID-19

Covid: Blood clot risk higher for six months after having virus

Haemoperfusion should only be used for COVID-19 in the context of

Scientists pinpoint mechanisms associated with severe COVID-19